Category: Government engagement
Register now
Posted by admin | May 19, 2017 | Uncategorized | 0
“Is that all?” Very little investment needed to sa...
Posted by admin | Sep 17, 2016 | Introduction | 0
Welcome
Posted by admin | Jul 11, 2016 | Introduction | 0
Introduction by Jean Carlet
Posted by admin | Apr 7, 2016 | Government engagement, Introduction | 0
2017
PopularImproving rational antibiotic treatment of common childhood conditions in Uganda
by admin | Jul 31, 2017 | 2017, Healthcare | 0
Dr Tamar Chitashvili, Md, Senior Improvement Advisor, University Research Co., Llc, Uganda; Dr Ekaterine Cherkezishvili, Md, Mph, Research Consultant, University Research Co., Llc, Uganda; Dr Esther Karamagi, Md, Mbchb, Msc,...
Economics and Innovation
LatestThe Economics of reducing antibiotic use to reduce antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...
-
-
Socioeconomics, antimicrobial use and antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
-
2017
MedTech Europe
Institut Merieux
Less than one cent to save a patient fro...
A National Action Plan to Contain Antimi...
MedTech Europe
The Global Point Prevalence Survey ̵...
Because taking care is the essence of he...
Healthcare
PopularDrug-Resistant Tuberculosis: What Is The Situation, What Are The Needs To Roll It Back?
by admin | Jul 26, 2017 | 2017, Healthcare | 0
Dr Karin Weyer, Coordinator, Laboratories, Diagnostics and Drug Resistance; Dr Dennis Falzon, Medical Officer; Dr Ernesto Jaramillo, Team Leader, Drug-Resistant TB Policies; Dr Matteo Zignol, Team Lead, Global Project on...
-
Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back
by admin | Jul 31, 2017 | 2017, Healthcare | 0
-
Intensive care units as epicentres for antimicrobial resistance development
by admin | Jul 31, 2017 | 2017, Healthcare | 0
-
Improving rational antibiotic treatment of common childhood conditions in Uganda
by admin | Jul 31, 2017 | 2017, Healthcare | 0
Economics and Innovation
Top RatedThe role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
Dr Christopher Houchens, Branch Chief, Antibacterial Program and Dr Joe Larsen Deputy Director, Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority, Office of Assistant Secretary for...
-
-
Socioeconomics, antimicrobial use and antimicrobial resistance
by admin | Aug 2, 2017 | 2017, Economics and Innovation | 0
-
All
LatestInterview: Malin Grape
by admin | Oct 17, 2022 | 2022 supplement | 0
Interview: Malin Grape AMR Control interviews Malin Grape, the newly appointed and first Swedish Ambassador for Antimicrobial Resistance The new AMR Ambassador, Malin Grape, is currently head of the Public Health Agency of...
- All
- Diagnostics
- Rational use of antibiotics
Interview: Malin Grape
by admin | Oct 17, 2022 | 2022 supplement
Interview: Malin Grape AMR Control interviews Malin Grape, the newly appointed and first Swedish Ambassador for Antimicrobial Resistance The new AMR Ambassador, Malin Grape, is currently head of the Public Health Agency of...
Augmented* medicine for all
by admin | Jul 19, 2016 | Diagnostics, Sponsored features
Fabienne Ostermeyer, International Development Director, Visiomed Group International Imagine if...
-
Diagnostics come of age to combat antimicrobial resistance
by admin | Jul 19, 2016 | Diagnostics, Sponsored features
-
Diagnostic innovation for antimicrobial resistance
by admin | Jul 11, 2016 | Diagnostics
-
Medical value of the rapid MRSA/SA screening in emergency surgery
by admin | Jul 11, 2016 | Diagnostics
The evolution of the global antibiotic resistance partnership
by admin | Sep 12, 2016 | Rational use of antibiotics
Hellen Gelband, Associate Director for Policy, Center for Disease Dynamics, Economics & Policy...
Categories
- 2016 (21)
- 2016 frontpage (4)
- 2017 (37)
- Alternatives to Antibiotics (2)
- Economics and Innovation (4)
- Governance (8)
- Healthcare (8)
- One Health (7)
- Supporters 2017 (6)
- 2017 frontpage (4)
- 2018 frontpage (5)
- 2018 frontpage français (4)
- 2019-1 (1)
- 2019-2 (1)
- 2019-3 (1)
- 2019-4 (1)
- 2022 supplement (1)
- Introduction (4)
- R&D innovation (5)
- Sponsored features (6)
- Supporters (3)
- Uncategorized (2)